(ACR) Acres Commercial Realty - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00489Q1022
ACR EPS (Earnings per Share)
ACR Revenue
ACR: Mortgage Loans, Commercial Loans, Equity Investments, Real Estate Investments
ACRES Commercial Realty Corp (NYSE:ACR) is a real estate investment trust that specializes in originating, holding, and managing commercial real estate mortgage loans and equity investments across the United States. The companys investment portfolio comprises a diverse range of commercial real estate credit investments, including floating-rate first mortgage loans, mezzanine financing, and preferred equity investments, allowing it to capitalize on various market opportunities.
As a mortgage REIT, ACRES Commercial Realty Corp generates income primarily through interest on its investments, and its ability to distribute at least 90% of its taxable income to shareholders exempts it from federal corporate income taxes. This structure enables the company to focus on maximizing shareholder value through strategic investments and efficient operations.
The companys investment strategy is geared towards exploiting market inefficiencies and capitalizing on opportunities in the commercial real estate sector. With its expertise in mortgage loan origination and equity investments, ACRES Commercial Realty Corp is well-positioned to navigate the complexities of the commercial real estate market and deliver strong returns to its investors.
Analyzing the
Forecasting the stocks performance, we can anticipate a potential rebound if the company continues to demonstrate strong investment performance and maintains its REIT status. With the current price below the 52-week high of $23.60, there is room for growth. If the stock breaks above its 50-day SMA, it may signal a bullish trend, potentially driving the price towards the 52-week high. Conversely, failure to break above the 50-day SMA may result in a continued downtrend. Based on the available data, a potential price target could be $21.50, representing a 15% increase from the current price.
Additional Sources for ACR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ACR Stock Overview
Market Cap in USD | 134m |
Sector | Real Estate |
Industry | REIT - Mortgage |
GiC Sub-Industry | Mortgage REITs |
IPO / Inception | 2006-02-07 |
ACR Stock Ratings
Growth Rating | 55.4 |
Fundamental | 24.0 |
Dividend Rating | 13.9 |
Rel. Strength | 18.4 |
Analysts | 3.5 of 5 |
Fair Price Momentum | 17.69 USD |
Fair Price DCF | 33.17 USD |
ACR Dividends
Currently no dividends paidACR Growth Ratios
Growth Correlation 3m | -38.2% |
Growth Correlation 12m | 86.8% |
Growth Correlation 5y | 33.9% |
CAGR 5y | 17.24% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.38 |
Alpha | 29.28 |
Beta | 0.005 |
Volatility | 28.80% |
Current Volume | 92.7k |
Average Volume 20d | 33.8k |
As of June 22, 2025, the stock is trading at USD 17.29 with a total of 92,746 shares traded.
Over the past week, the price has changed by -4.00%, over one month by -8.03%, over three months by -26.05% and over the past year by +33.51%.
Neither. Based on ValueRay´s Fundamental Analyses, Acres Commercial Realty is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 23.95 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACR is around 17.69 USD . This means that ACR is currently overvalued and has a potential downside of 2.31%.
Acres Commercial Realty has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold ACR.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, ACR Acres Commercial Realty will be worth about 19.1 in June 2026. The stock is currently trading at 17.29. This means that the stock has a potential upside of +10.47%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 22 | 27.2% |
Analysts Target Price | 22 | 27.2% |
ValueRay Target Price | 19.1 | 10.5% |